ECSP15009830A - Ciclopentilpirazoles como bloqueadores del canal de calcio tipo n - Google Patents

Ciclopentilpirazoles como bloqueadores del canal de calcio tipo n

Info

Publication number
ECSP15009830A
ECSP15009830A ECIEPI20159830A ECPI201509830A ECSP15009830A EC SP15009830 A ECSP15009830 A EC SP15009830A EC IEPI20159830 A ECIEPI20159830 A EC IEPI20159830A EC PI201509830 A ECPI201509830 A EC PI201509830A EC SP15009830 A ECSP15009830 A EC SP15009830A
Authority
EC
Ecuador
Prior art keywords
cyclopentilpyrazoles
calcium channel
channel blockers
type calcium
type
Prior art date
Application number
ECIEPI20159830A
Other languages
English (en)
Inventor
Zhihua Sui
Christopher Flores
Michael Winters
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49036654&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP15009830(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ECSP15009830A publication Critical patent/ECSP15009830A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C07D491/113—Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

ver anexo
ECIEPI20159830A 2012-08-16 2015-03-13 Ciclopentilpirazoles como bloqueadores del canal de calcio tipo n ECSP15009830A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261683775P 2012-08-16 2012-08-16

Publications (1)

Publication Number Publication Date
ECSP15009830A true ECSP15009830A (es) 2015-12-31

Family

ID=49036654

Family Applications (1)

Application Number Title Priority Date Filing Date
ECIEPI20159830A ECSP15009830A (es) 2012-08-16 2015-03-13 Ciclopentilpirazoles como bloqueadores del canal de calcio tipo n

Country Status (21)

Country Link
US (1) US8853418B2 (es)
EP (1) EP2885279A1 (es)
JP (1) JP6262231B2 (es)
KR (1) KR20150042270A (es)
CN (1) CN105189464B (es)
AU (1) AU2013302469B2 (es)
BR (1) BR112015003328A2 (es)
CA (1) CA2882042A1 (es)
CL (1) CL2015000357A1 (es)
CR (1) CR20150068A (es)
EA (1) EA201590382A1 (es)
EC (1) ECSP15009830A (es)
HK (1) HK1217690A1 (es)
IL (1) IL237189A0 (es)
IN (1) IN2015DN01237A (es)
MX (1) MX2015002037A (es)
PE (1) PE20151137A1 (es)
PH (1) PH12015500314A1 (es)
SG (1) SG11201501140RA (es)
WO (1) WO2014028801A1 (es)
ZA (1) ZA201501746B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014028800A1 (en) 2012-08-16 2014-02-20 Janssen Pharmaceutica Nv Substituted pyrazoles as n-type calcium channel blockers
US9453002B2 (en) 2013-08-16 2016-09-27 Janssen Pharmaceutica Nv Substituted imidazoles as N-type calcium channel blockers
EP2957559A1 (en) * 2014-06-18 2015-12-23 L'Universite de Strasbourg Iminosydnone derivatives for conjugation and release of compounds of interest

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1287174B1 (it) * 1996-11-15 1998-08-04 Angelini Ricerche Spa Diaril-ciclometilenpirazoli farmacologicamente attivi,procedimento per prepararli e composizioni farmaceutiche che li contengono
JP2001220390A (ja) * 2000-02-09 2001-08-14 Yamanouchi Pharmaceut Co Ltd 縮合ピラゾール誘導体
AU2005221138A1 (en) * 2004-03-08 2005-09-22 Wyeth Ion channel modulators
CN1938281A (zh) * 2004-03-08 2007-03-28 惠氏公司 离子通道调节剂
EP1963275A2 (en) * 2005-11-09 2008-09-03 Abbott Laboratories P2x7 receptor antagonists and uses thereof

Also Published As

Publication number Publication date
EP2885279A1 (en) 2015-06-24
JP6262231B2 (ja) 2018-01-17
CA2882042A1 (en) 2014-02-20
US20140051660A1 (en) 2014-02-20
KR20150042270A (ko) 2015-04-20
JP2015524851A (ja) 2015-08-27
PH12015500314A1 (en) 2015-03-30
ZA201501746B (en) 2017-08-30
HK1217690A1 (zh) 2017-01-20
BR112015003328A2 (pt) 2017-07-04
AU2013302469A1 (en) 2015-02-26
CR20150068A (es) 2015-04-30
CL2015000357A1 (es) 2015-06-12
CN105189464A (zh) 2015-12-23
PE20151137A1 (es) 2015-08-07
US8853418B2 (en) 2014-10-07
IN2015DN01237A (es) 2015-06-26
WO2014028801A1 (en) 2014-02-20
CN105189464B (zh) 2017-12-12
SG11201501140RA (en) 2015-04-29
IL237189A0 (en) 2015-04-30
EA201590382A1 (ru) 2015-08-31
AU2013302469B2 (en) 2017-08-24
MX2015002037A (es) 2016-01-22

Similar Documents

Publication Publication Date Title
SMT201700053B (it) Derivato del cicloalcano
IL237190A0 (en) Pyrazoles are converted as n-type calcium channel blockers
UY34601A (es) ?mezclas fungicidas de pirazol?.
CR20150069A (es) Pirrolopirazoles como bloqueadores del canal de calcio tipo n
UY34820A (es) Compuestos tipo pirrolo-pirrolidinona
CO7151512A2 (es) Inhibidores del nampt
IL237192A0 (en) Pyrrolopyrazoles as n-type calcium channel blockers
IN2013DE00266A (es)
IN2014DE01038A (es)
CR20150144A (es) Derivados de etinilo como moduladores del receptor de actividad mglur5
BR112015011037A2 (pt) poste
UY34349A (es) OCTAHIDROPIRROLO[1,2-a]PIRAZINA SULFONAMIDAS SUSTITUIDAS COMO BLOQUEADORES DE CANALES DE CALCIO
BR112015001072A2 (pt) misturas refrigerantes
ECSP15009830A (es) Ciclopentilpirazoles como bloqueadores del canal de calcio tipo n
BR112014017057A2 (pt) máquina de tratamento de tecido dotada de elementos de impacto
BR112014029620A2 (pt) unidade de ventilação
BR112014027843A2 (pt) análogos de hexa-depsipeptídeo como compostos anticancerígenos
IL243683A0 (en) Imidazoles are converted as n-type calcium channel blockers
UY34613A (es) Composición de limpieza
BR112015000468A2 (pt) composição detergente
CR20130229S (es) Banda de rodadura de neumático
ECSP15010205A (es) Nuevos compuestos inhibidores de la fosfodiesterasa del tipo 10a
BR112014028427A2 (pt) sulfonamidas contendo carbazola como moduladores de criptocromo
CR20130482S (es) Motocicleta
UY34760A (es) Compuesto bicíclico